Sort
21,453 grants matching “tuberculosis”
CMOS-Integrated Fluorescence Biochip SBIR Phase II Grant Application
$810,812Arjang Hassibi · Insilixa, Inc. · R44 · FY2015 · HG
Preclinical modeling to study Tuberculous Meningitis
$810,795Sanjay Jain · Johns Hopkins University · R01 · FY2021 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$810,615Krishna P Reddy · Massachusetts General Hospital · R01 · FY2022 · AI
Video DOT and Economic Incentives to promote adherence to LTBI therapy
$810,520Maunank Shah · Johns Hopkins University · R01 · FY2025 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$809,949Chetan Seshadri · University Of Washington · R01 · FY2023 · AI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis
$809,946Yuri Bushkin · Rbhs-New Jersey Medical School · R01 · FY2016 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$809,775Krishna P Reddy · Massachusetts General Hospital · R01 · FY2024 · AI
Biochemistry of Energy-Dependent (Intracellular) Protein Degradation
$809,583Michael Maurizi · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Human immune signatures of natural immunity to DENV infection, severe disease, and vaccination with attenuated live vaccine
$809,195Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2019 · AI
A STINGing vaccine for TB
$808,927William Ramses Bishai · Johns Hopkins University · R01 · FY2021 · AI
The role of tyrosine metabolism in tuberculosis pathogenesis
$808,795Sara Suliman · University Of California, San Francisco · R01 · FY2024 · AI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$808,450Mark Hatherill · University Of Cape Town · R01 · FY2021 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$808,335Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Minimizing in vivo Drug Tolerance induction in tuberculosis.
$808,212David G Russell · Rutgers Biomedical And Health Sciences · U19 · FY2024 · AI
DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME
$808,201Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
Video DOT and Economic Incentives to promote adherence to LTBI therapy
$808,064Maunank Shah · Johns Hopkins University · R01 · FY2024 · AI
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
$807,746Christopher Vinnard · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
$807,677Jeffrey Aube · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine
$807,595Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$807,566Joy Sennett · Mississippi State Department Of Health · U52 · FY2008 · PS
Core B - Developmental
$807,453Ira B Wilson · Miriam Hospital · P30 · FY2021 · AI
Molecular basis of antibiotic resilience in Mycobacterium tuberculosis
$807,344Sarah M Fortune · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · AI
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
$807,340Anna Bershteyn · New York University School Of Medicine · R01 · FY2022 · MH
TUBERCULOSIS ELIMINATION AND LABORATORY
$807,189Sue M Percifield · Indiana State Department Of Health · U52 · FY2006 · PS
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$806,919Mark Hatherill · University Of Cape Town · R01 · FY2024 · AI